May 2021 Simoa® Publications: Other Research Areas
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus
Karnell JL, et al.
Sci Transl Med. 2021 May 26;13(595):eabf8442
Inflammation
Histone H3 N-terminal mimicry drives a novel network of methyl-effector interactions
Chen J, et al.
Biochem J. 2021 May 28;478(10):1943-1958
Oncology
IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK
Lehman CE, et al.
Sci Rep. 2021 May 24;11(1):10826
Oncology
LRIG1 is a gatekeeper to exit from quiescence in adult neural stem cells
Marqués-Torrejón M, et al.
Nat Commun. 2021 May 10;12(1):2594
Oncology
Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance)
Quintanilha JCF, et al.
Angiogenesis. 2021 May 24
Oncology
Emerging methods in biomarker identification for extracellular vesicle-based liquid biopsy
Liang Y, et al.
Journal of Extracellular Vesicles. 2021;10:e12090
Simoa Technology
May 2021 Simoa® Publications in Other Therapeutic Areas
